However, as it blocks the interactions of PD-1 with both PD-L1 and PD-L2 [52], it may act not only in the periphery but also within the tumor sites, interfering with T cell/tumor cell interactions and evoking specific, localized stimulation. The gene discussed is CD274; the disease is neoplasm.